Basic Information


GTO ID GTC3417
Trial ID NCT05827978
Disease Seasonal Influenza
TherapymRNA vaccine
Treatment mRNA-1010
PhasePhase3
Recruitment statusActive, Not Recruiting
TitleA Phase 3, Randomized, Stratified, Observer-Blind, Active-Controlled Study to Evaluate the Immunogenicity, Reactogenicity and Safety of mRNA-1010 Seasonal Influenza Vaccine in Adults 18 Years and Older
Year2023
CountryUnited States
Company sponsorModernaTX, Inc.
Other ID(s)mRNA-1010-P303
Vector information
Vectorlipid nanoparticle

Clinical Result

Cohort1: mRNA-1010
Administration route intramuscular injection
Dosage mRNA-1010, single dose, on Day 1
Age Adult, Older_Adult
Cohort2: Fluarix Quadrivalent
Administration route intramuscular injection
Dosage Licensed Quadrivalent Inactivated Seasonal Influenza Vaccine, 25 ug, single dose, on Day 1
Age Adult, Older_Adult

Relationship Graph

Overview of Knowledge Graph